ketotifen has been researched along with Osteosclerosis in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Osteosclerosis: An abnormal hardening or increased density of bone tissue.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mezei, P | 1 |
| Bencsik, Z | 1 |
| Vicze, B | 1 |
| Simon, K | 1 |
| István, L | 1 |
| Pajor, L | 1 |
1 other study available for ketotifen and Osteosclerosis
| Article | Year |
|---|---|
[Two cases of malignant and benign systemic mastocytosis].
Topics: Adult; Bone Marrow; Ethylenediamines; Fatal Outcome; Female; Femur; Histamine H1 Antagonists; Humans | 1999 |